Table 2. . Relative risk of developing melanoma compared with relative risk of developing other US Preventive Services Task Force grade A/B diseases.
Melanoma risk factors | Melanoma RR/†OR | Comparable disease (risk factor) | Comparable disease RR/OR | Comparable screening modality |
---|---|---|---|---|
One atypical nevus vs 0* | 1.5 [24] | High BP (overweight vs normal BMI) | †1.5 [33] | BP cuff |
Total common nevi 16–40 vs <15* | 1.5 [24] | High BP (overweight vs normal BMI) | †1.5 [33] | BP cuff |
Blue eye color vs dark* | 1.5 [40] | High BP (overweight vs normal BMI) | †1.5 [33] | BP cuff |
Hazel eye color vs dark* | 1.5 [40] | High BP (overweight vs normal BMI) | †1.5 [33] | BP cuff |
Green eye color vs dark* | 1.6 [40] | Type II diabetes (overweight vs normal BMI) | †1.6 [34] | Blood test |
Light brown hair vs dark* | 1.6 [40] | Type II diabetes (overweight vs normal BMI) | †1.6 [34] | Blood test |
Indoor tanning ever use in men/women vs never use* | †1.7 [41] | Type II diabetes (overweight vs normal BMI) | †1.6 [34] | Blood test |
Fitzpatrick II vs IV*§ | 1.8 [40] | High BP (obese vs normal BMI) | †1.9 [33] | BP cuff |
Fitzpatrick III vs IV* | 1.8 [40] | |||
History of sunburn vs no history* | 2.0 [42] | Lipid disorders (obese vs normal BMI) | †1.9 [34] | Blood test |
Blond hair vs dark* | 2.0 [40] | Lipid disorders (morbidly obese vs normal BMI) | †1.9 [34] | Blood test |
2 atypical nevi vs 0* | 2.1 [24] | Lipid disorders (morbidly obese vs normal BMI | †1.9 [34] | Blood test |
Fitzpatrick I vs IV* | 2.1 [40] | Lipid disorders (morbidly obese vs normal BMI | †1.9 [34] | Blood test |
High density of freckles vs low* | 2.1 [40] | Breast cancer (first degree relative vs no relative) | 2.1 [38] | Mammogram |
Total common nevi 41–60 vs <15* | 2.2 [24] | Breast cancer (first degree relative vs no relative) | 2.1 [38] | Mammogram |
Indoor tanning ever use in women aged 40–49 vs never use* | †2.3 [8] | Breast cancer (first-degree relative vs no relative) | 2.1 [38] | Mammogram |
Family history of melanoma in 1 or more 1st degree relative¶ | 1.7–3.0 [40,43–44] | AAA (ever smoker vs never smoker) | †3.1 [36] | Ultrasound |
3 atypical nevi vs 0¶ | 3.0 [24] | AAA (ever smoker vs never smoker) | †3.1 [36] | Ultrasound |
Total common nevi 61–80 vs <15¶ | 3.3 [24] | Type II diabetes (obese vs normal BMI) | †3.4 [34] | Blood test |
Red hair vs dark¶ | 3.6 [40] | High blood pressure (high-normal BP vs normal BP) | †3.5 [33] | BP cuff |
History of AK and/or KC vs no history¶ | 4.3 [40] | High blood pressure (high-normal BP vs normal BP) | †3.5 [33] | BP cuff |
Indoor tanning ever use in women aged 30–39 years vs never use¶ | †4.3 [8] | AAA (male vs female) | 5.7 [35] | Ultrasound |
4 atypical nevi vs 0¶ | 4.4 [24] | AAA (male vs female) | 5.7 [35] | Ultrasound |
Indoor tanning ever use in women aged <30 years vs never use# | †6.0 [8] | Breast cancer (BRCA1 mutation carriers) | 6.1 [37] | Mammogram |
5 atypical nevi vs 0# | 6.4 [24] | Type II diabetes (morbidly obese vs normal BMI) | †7.4 [34] | Blood test |
Total common nevi 101–120 vs <15# | 6.9 [24] | Lung cancer (current female smoker vs never smoker) | †7.8 [39] | CT scan |
Personal history of melanoma# | ‡8.2–13.4 [45] | Lung cancer (30–40 pack-year smoking history in woman) | †12.9 [39] | CT scan |
CDKN2A mutation carrier# | §14–28 [46] | Lung cancer (current male smoker vs never) Lung Cancer (30–40 pack-year smoking history in males) |
†23.6 [39] †24.6 [39] |
CT scan CT scan |
The diseases and malignancies chosen for comparisons have received US Preventive Services Task Force grade A or B screening recommendations based on risk. Comparable risk factors are listed in order of increasing risk (* signifies minimally increased risk, ¶ signifies moderately increased risk, # signifies greatly increased risk).
†Odds ratio.
‡Risk estimate ranges based on risk at age ≥50 years and risk at age <30 years.
§Risk estimate range based on risk at age 50 years and risk at age 80 years.
AAA: Abdominal aortic aneurysm; AK: Actinic keratosis; BP: Blood pressure; BMI: Body mass index; KC: Keratinocyte carcinoma.